Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses
Recruiting
Observational Study
Peritoneal Carcinomatosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 250 (estimated)
- Sponsor
- University of Regensburg · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* suspicious peritoneal carcinomatosis
Exclusion Criteria:
* \<18 years
Contacts